S

Director Director DIN 00903598
DIN 00903598 First appointment Mar 2006 Primary industry Financial Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Sekar

Data last updated:

Sekar was a Director at The Mylapore Hindu Permanent Fund Nidhi Limited (2006–2015) and Director at Apharmo Limited (from 2010). The companies operate in Financial Services.

DIN 00903598
Primary Designation Director
Industry Financial Services
First Appointment 20 Mar 2006
Oldest Company Age 33 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Mar 20061872₹60.13 Cr (FY 2023)Active
Apharmo Limited U24231TN1993PLC025375
Director15 Jan 20101993Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apharmo Limited
The Mylapore Hindu Permanent Fund Nidhi Limited
Premium access

Shareholding and investment profile for Sekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sekar

Sekar was first appointed on 20 Mar 2006 as Director at The Mylapore Hindu Permanent Fund Nidhi Limited. The most recent appointment on record is 15 Jan 2010 at Apharmo Limited.

Sekar held 2 earlier board appointments: The Mylapore Hindu Permanent Fund Nidhi Limited (Director, 20 Mar 2006 to 10 Aug 2015); Apharmo Limited (Director, from 15 Jan 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available